© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Shikimic acid probably sounds new to some, but its background stretches into the 19th century. Botanists originally isolated it from Japanese star anise, a plant prized across Asia for centuries. Research picked up in the 1940s, at a time when folks started figuring out there were a handful of plant acids with huge value. People first recognized this acid for its place in how plants make aromatic amino acids, a process essential to the foundation of biochemistry. The word “shikimic” comes from the Japanese name for star anise, “shikimi,” capturing a bit of the acid’s cross-cultural story. Over the last century, researchers realized its pivotal part in pharmaceutical development, most famously as a building block for oseltamivir, better known as Tamiflu.
Shikimic acid shows up today as a colorless, water-soluble, crystalline solid. It often gets packaged in pharmaceutical-grade batches due to heavy demand from vaccine and antiviral manufacturers. In the lab and in the factory, shikimic acid rarely exists outside pure, isolated form, since impurities undermine downstream synthesis. The bulk of shikimic acid available in global markets comes from plant extraction and bioengineered fermentation, with each method bringing its own stories of cost, yield, and regulatory questions. Most commercial product winds up in sealed, food-grade drums or sealed glass bottles, labeled with origin, purity levels, moisture content, and recommended storage temperatures around 2–8°C.
You won’t mistake shikimic acid in the lab. Its melting point usually sits right around 169–170°C. It dissolves in water without a fuss, and it shows moderate solubility in alcohol. Structurally, shikimic acid doesn’t look fancy: a cyclohexene ring, three hydroxyl groups, one carboxylic acid, and an unsaturation that gives it mild reactivity. It stacks up as a weak acid, measuring a pKa of about 4.1 for its carboxyl group, and displays optical activity due to its multiple chiral centers. The acidic hydrogen atoms give the molecule chemical “handles” that open up opportunities in synthesis and modification, a feature synthetic chemists prize.
Labs and industrial buyers don’t just demand high-purity shikimic acid—they require documentation normal folks would find obsessive. Certified lots ship with statement-of-purity reports, batch numbers, source plant or fermentation organism details, HPLC chromatograms, and microbiological test results. Brands often stamp “for research use only” on smaller lab packs, while manufacturers selling to pharma outfits focus on pharmacopoeial compliance, aiming for over 98% purity, minimal residual solvents, absence of heavy metals, and precise water content, since even a teaspoon of water out of place ruins a costly process. Labels always list CAS number 138-59-0, quality grade (research or pharma), molecular formula (C7H10O5), and recommended handling procedures.
For much of the 20th century, herbalists and chemists had to rely on slow, tedious extraction from star anise pods. Extraction involved soaking, boiling, filtration, and several rounds of crystallization, leaving environmental and economic scars. In recent decades, fermentation started making a splash: genetically engineered E. coli or yeast work overtime converting glucose into shikimic acid, freeing pharmaceutical supply chains from their total dependence on botanicals, particularly when avian flu epidemics drove up demand. Bioengineered routes offer sustainability and price stability, transforming how companies think about sourcing and geopolitics. Still, raw plant extraction continues, because setting up a fermentation operation requires heavy investment and technical experience.
Chemists see shikimic acid as versatile. Its three hydroxyl groups, carboxyl group, and double bond open it up for dozens of reactions. The conversion to oseltamivir stands out, a lengthy process involving selective protection, oxidation, reduction, and at least four chiral steps. Beyond antivirals, chemists modify shikimic acid to create new chiral auxiliaries, intermediates for sweetener analogs, and oddball molecular frameworks for medicinal chemistry. Each functional group becomes a target: carboxyl acts as a springboard for esterification or amide formation; hydroxyls undergo acylation or alkylation, and the ring system allows cycloadditions or deoxygenations depending on the needs of the day.
Don’t get confused by the labels—a single molecule sometimes wears dozens of names. Shikimic acid also pops up as “(3R,4S,5R)-3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid” in chemical catalogs. Industry suppliers may call it “Star anise acid,” “Skikimat,” or “Shikimate,” particularly on global storefronts and import documents. For patent applications, systematic IUPAC nomenclature prevails. No matter the alias, researchers searching for the compound usually trace it back through CAS number 138-59-0.
Working with shikimic acid poses its usual lab risks, but nothing outside the realm of standard organic acids. Oral, dermal, or inhalational exposure at industrial levels doesn’t usually lead to acute symptoms, but nobody wants repeated or high-level contact. Gloves and safety glasses sit non-negotiable on the bench. In powder or crystalline form, dust inhalation gets flagged, so fume hoods and masks often come into play. The chemical stays stable at typical storage conditions, with refrigeration extending shelf life and stalling decomposition. In pharmaceutical plants, every step follows GMP (Good Manufacturing Practice) principles—full traceability, managed waste, regular audits, batch documentation, and cross-contamination controls.
These days, shikimic acid finds its calling card printed mostly in pharma. No industry gobbles up more, since the compound stands as the key raw material for synthesizing antiviral drugs—most notably oseltamivir and zanamivir. R&D chemists seize upon it for synthesizing complex organic molecules, sometimes as a “chiral pool” source or as a starting platform for intricate natural product research. Food scientists occasionally explore shikimic acid for flavor modification, though its sour-bitter taste holds niche appeal. Plant biologists run experiments disrupting the shikimate pathway to investigate herbicide targets, given that many vital crop inhibitors block this very system, causing heated debates about food security and glyphosate use. Cosmetic manufacturers trial shikimic acid in formulations as they chase new natural actives, but the scale pales next to pharmaceutical demand.
Researchers refuse to let shikimic acid’s uses stagnate. Synthetic biologists keep tweaking microorganisms for greater, faster yield, making shikimic acid less dependent on specialty crops vulnerable to trade wars or climate. Chemists hunt for gentle, high-atom-efficiency routes for converting shikimic acid into medical intermediates, pressured by ever-tightening environmental and cost regulations. A team in China might announce an enzymatic pathway that halves waste; a biotech startup in Europe may engineer E. coli strains with record output; a pharma conglomerate in the US probably files patents for extracting and converting shikimic acid in modular reactors, cutting response time when a flu epidemic looms. The molecule sits at the center of countless grant proposals and journal articles—everyone wants a slice of its value, hoping breakthroughs can slash costs or open new markets.
Toxicologists pay close attention to shikimic acid, though data suggest its risk factor stays modest for humans in pharmaceutical doses. Animal studies show that significant ingestion fails to trigger the kind of acute toxicity seen with pesticides or heavy metals. Still, chronic exposure studies continue, especially as people start consuming more processed herbal extracts. Researchers also watch for cross-reactions with high doses of plant phenolics, since metabolic bottlenecks can worsen underlying conditions in sensitive populations. Regulatory agencies keep ongoing surveillance, especially since the world relies so heavily on shikimic acid for the annual assembly lines of antiviral drugs.
Looking ahead, people working in life sciences bet big on shikimic acid’s growing utility. The rise of antibiotic resistance drives more investment toward discovering new classes of drugs, many of which grow out of plant-inspired or shikimate-related scaffolds. Bioengineers working with CRISPR and automation dream of microbial reactors churning out shikimic acid from waste sugars, turning food waste into gold. As climate change upends agriculture, more resilient supply chains built on biofermentation could insulate pharmaceutical makers from volatile harvests and trade blockades. With consumers growing hungry for “green chemistry,” market pressure pushes innovators to drop toxic reagents and pump out cleaner, shikimic acid–based syntheses. The story keeps evolving—every new research article pushes the edges, and every flu season reminds governments of how critical this molecule remains.
Shikimic acid often gets tucked away in chemistry textbooks, but it quietly plays a starring role in both science and daily life. I first came across shikimic acid while reading about how certain medicines are made. Pretty soon, I started spotting its name in the middle of supply chain debates, stories about antiviral drugs, and even natural remedies.
Most folks who’ve faced a nasty flu have heard of Tamiflu, one of the most popular antiviral medications around. Shikimic acid provides a critical starting point for making this medicine. Nearly all the world’s commercial supply gets extracted from star anise, a spice found in many Asian kitchens. The influenza virus changes all the time, and when outbreaks hit, demand for Tamiflu jumps. As a result, the price of star anise sometimes spikes. I remember hearing about shortages and sudden price hikes, and it made me realize that what goes into our drugs can quickly become a global concern.
Star anise isn’t the only source. Firms now use genetically modified bacteria to produce shikimic acid in labs, helping smooth out supply. Still, star anise remains the original hero. Each time flu season approaches, farmers and suppliers gear up, knowing their harvest could mean the difference between widespread relief and empty pharmacy shelves. The process also presses on urgent questions—how to create a steady supply chain without straining communities or the environment.
Medical breakthroughs get the headlines, but shikimic acid does more than fuel flu drugs. It’s a building block for many chemicals used in the making of sweeteners, fragrances, and food additives. Some toothpaste and household cleaners owe their smooth texture to this molecule. Even scientists studying cancer, bacteria, or plant diseases use it as a research tool. At home, it sometimes pops up in skin care—some folks use creams and serums that tout its natural, anti-inflammatory perks.
One challenge sticks out. If most shikimic acid relies on star anise or on a single type of lab-made strain, supply struggles during epidemics might not vanish. And if demand suddenly surges, farmers and factories might face pressure to cut corners or over-farm. Over the years, I’ve seen communities wrestle with short-term profit versus long-term soil health. Answering these dilemmas calls for smart investment in biotech. Diversifying sources, developing greener production techniques, and supporting ethical farming would all help secure what communities need—without burning out the earth.
Shikimic acid reminds me how something overlooked can quietly shape both science and society. Whether it’s the medication on the pharmacy shelf or the smooth finish in a cleansed home, this compound touches everyday life in ways most people rarely hear about.
Every time I read about researchers finding new uses for plant-based molecules like shikimic acid, I feel hopeful. Simple innovations, thoughtful sourcing, and smarter policies build real resilience. It’s proof to me that the path from plant to pill depends as much on curiosity and care as it does on chemistry.
Shikimic acid comes from a few natural sources, most famously from star anise, but also from apples and some plants. Companies use it in certain skincare products, pointing to its exfoliating and anti-inflammatory traits. Some dermatologists say it helps loosen up dead skin cells, making it a gentler exfoliant compared to everyday alpha-hydroxy acids (AHAs) like glycolic acid.
There are plenty of chemical exfoliants out there. Glycolic and lactic acids have a mountain of research supporting use on skin, so the bar sits high for newcomers like shikimic acid. What sets this ingredient apart is its tendency to exfoliate without stinging. For people with delicate or redness-prone skin, products heavy in glycolic acid can push skin right over the edge. In several small studies, shikimic acid produced milder reactions. Some people said their skin looked brighter and felt smoother without the usual burning or peeling you’d spot with stronger chemical acids.
A few peer-reviewed studies suggest topical shikimic acid can speed up cell turnover and help manage oil. Research in the Journal of Cosmetic Dermatology hints at stoppage of overactive bacteria and showed a modest improvement in acne, possibly because of its anti-inflammatory action. Compared to classic AHAs or BHA (like salicylic acid), shikimic acid hasn’t attracted as much attention from researchers yet, so the findings so far come from small samples or petri-dish experiments.
The European Union has reviewed the ingredient, citing data indicating shikimic acid is not sensitizing or toxic when used in cosmetics at reasonable levels. This nod from European safety boards gives some reassurance. The U.S. Food and Drug Administration does not single out shikimic acid as unsafe, though that doesn’t mean hands-off approval either.
In real life, friends and clients who dabble in shikimic acid serums notice better results when using it two or three times a week alongside a quality moisturizer. It leaves their skin soft with less irritation, though no miracle overnight transformations. Redness and flaky spots simmer down after a few weeks. I’ve tested some formulas on both oily and dry skin with little negative effect—just stay away from raw extracts, which can get harsh.
Anyone who deals with allergies or has a low tolerance for plant-based skincare should still spend time on patch tests before any real commitment. Just because an ingredient shows low irritation in trials doesn’t mean everyone’s skin will accept it. It’s best to watch carefully after the first few applications.
No single ingredient changes everything about skin. What matters is pairing shikimic acid with gentle cleansers, broad-spectrum sunscreen, and simple hydration. If a rash or swelling crops up, products need to go back on the shelf. Doctors recommend talking with a dermatologist before making big changes, especially for folks prone to eczema, rosacea, or severe acne.
People searching for softer exfoliation can ask about shikimic acid as an option. The ingredient looks promising, but long-term studies still need to catch up. Stick to brands that share honest, clear labels and don’t chase miracles—steady, careful use wins out every time.
Shikimic acid pops up often in news stories about alternative medicine and antiviral drugs. Pulling from its roots in the Chinese star anise plant, companies use this compound as a starter for Tamiflu, an influenza treatment. Some skincare brands talk up its exfoliating or anti-inflammatory potential, while others pitch it as an immune booster, powdered supplement, or herbal extract. Curiosity about its side effects comes naturally, especially for anyone thinking about self-medicating or experimenting with trendy new products.
Too much hype around any natural ingredient risks overshadowing real risks. Shikimic acid, on its own, rarely appears in consumer products except in low concentrations, so side effects tend to be less dramatic than pharmaceutical drugs. Most of the available safety data comes from its use in medications. Nausea, stomach upset, diarrhea, and headaches appear on safety reports, mainly linked to its derivative, oseltamivir.
Anyone with sensitivities or allergies to plant-based compounds could face mild reactions, like rashes or itching, after topical use. As a person with lifelong eczema, I watch ingredient labels closely because even “natural” additives may trigger a flare. A patch test with skincare products makes sense, especially if you’re prone to skin irritation.
Online stories sometimes claim shikimic acid can “detoxify” spike proteins or reverse long-term vaccine effects. The science doesn’t back up those bold claims. Many stories reuse the same handful of mouse or petri dish studies to justify any number of uses. No evidence shows that shikimic acid, either alone or in supplements, protects against viruses outside of its established role as a Tamiflu precursor. This matters, because acting on misleading wellness advice has its own risks. I’ve met clients convinced that a new supplement will solve all their health problems, only to run into side effects or interactions with regular medications.
Pregnant and breastfeeding women probably shouldn’t venture into shikimic acid territory unless a healthcare provider gives the green light. Kids haven’t been included in research looking at long-term or high-dose exposure, so their safety profile remains guesswork. Anyone with kidney problems, liver issues, or autoimmune disorders should talk to their doctor before mixing new supplements or herbal extracts into their regimen.
The supplement market remains lightly regulated, especially for plant-derived compounds like shikimic acid. Buying from trusted brands, checking for third-party testing, and researching potential interactions pays dividends in safety. If you take blood thinners or have a chronic illness, double-check with a medical professional before starting anything new. Even as more research crops up on lesser-known compounds, getting advice from a real person with medical training gives you peace of mind that clicking around on a forum or social media just can’t provide.
Scrolling past viral claims about miracle cures or secret solutions, it helps to slow down and look for real-world evidence. With any substance, including shikimic acid, the dose makes the poison. Good health doesn’t rely on chasing the latest extract in powder or pill form. Listening to your body and talking openly to knowledgeable professionals makes the biggest difference.
You pick up a bottle with shikimic acid on the label and wonder, “Is this the new trend, or does it actually help?” Here’s the thing: shikimic acid isn’t just a buzzword. Our skin is facing plenty of challenges daily—pollution, uneven tone, flaky patches, stubborn spots. Shikimic acid steps in as a plant-based exfoliator, breaking down the glue that keeps dead skin stuck to the surface.
I like to look at the research before getting excited. Studies have shown shikimic acid works gently, especially compared with rougher acids. It loosens up dead cells—letting the smoother, more radiant layer come up without a harsh sting. And unlike strong glycolic peels, it rarely causes extreme redness.
If your skin gets sensitive with classic chemical exfoliants, this could be your answer. Some research points to anti-microbial and anti-inflammatory effects, which benefits those with red, bumpy patches or recurring breakouts. Dermatologists in Europe have started to add shikimic acid products into routines for people who need mild resurfacing. It catches the interest of those of us who hit a wall with stronger acids and retinoids.
The directions on bottles usually say to apply a small amount to clean, dry skin, often once or twice a week. A lot of people get eager and overdo it. From personal experience, I found my skin gave the best results when I paced myself. I gave it two weeks before deciding if it fit my skin. No burning, no flaking—just a gentle improvement in texture. I waited until my skin dried after washing, dotted a pea-sized amount all over, and skipped anything else harsh on those nights.
Layering matters. Pat on moisturizer after, not before. If you use sunscreen in the morning—and you should—don’t skip it. Softer skin still needs protection, even more so since exfoliation makes it thirstier for UV protection. Shikimic acid doesn’t erase sun risks.
Dealing with breakouts? Shikimic acid tackles congestion and clogged pores, but always check for added ingredients. Sensitive types do better with a minimalist formula. My friend with chronic redness found one shikimic acid serum that kept her flares calmer, where lactic acid only gave her rashy patches.
For stubborn pigmentation, don’t expect overnight changes. Keep expectations realistic. Shikimic acid acts as an assistant for brightening agents like vitamin C or licorice root extract. Using it a few times a week clears the way so these ingredients work better.
Look at the label for the concentration, and do a patch test. Some brands stay vague about the exact percentage. Aim for a concentration under 10% at first. If your skin stings or flakes, dial back. Irritation can undo any benefits. If you spot improvement—softer skin, fewer rough bits, less redness—count that as a win.
Better skin sometimes comes from simple swaps, not flashy ingredients. I found that sticking to gentle, plant-based acids brought steady progress without drama. That’s what shikimic acid has delivered for those I know who have tried it smartly.
Dealing with acne brings the sort of frustration regular skin treatments don’t always solve. Folks hunting for the next new thing have started asking about shikimic acid. This compound pops up naturally in plants like star anise, and for a while, it stayed behind the scenes as something mostly used in the drug industry. Recent beauty buzz pulled it right into the acne spotlight.
Dermatology research points out that shikimic acid—similar to better-known alpha-hydroxy acids (AHAs)—breaks down dead skin cells. Like glycolic and lactic acid, it smooths skin by encouraging gentle exfoliation. My own skin story runs through years of trying harsh scrubs and spot treatments, some of which stung or left marks. Products built around milder acids, when layered into a simple routine, delivered the only results I could stick with day in and day out. Shikimic acid works in much the same way by softening the top layer of skin, helping clogged pores stay clear.
Inflamed bumps make acne stand apart from the odd blackhead or whitehead. Researchers in Japan and Europe have noticed shikimic acid blocking the growth of certain bacteria—like Propionibacterium acnes—linked to breakouts. This antibacterial twist sets it apart, at least on paper, from the strictly exfoliating acids crowding store shelves.
When acne carries both oil build-up and bacterial action, most folks reach for heavy-duty spot creams or prescription pills. But overuse runs the risk of dryness, redness, or angry skin flare-ups. Natural compounds like shikimic acid might help folks dodge some common problems, especially for those with sensitive skin or those tired of harsh chemical peels.
Scrolling through social feeds, I’ve seen more skin-care creators talk up serums and toners with shikimic acid in the ingredients list. The best products draw from published studies and are clearly labeled, but many options play up buzzwords without much evidence. Quality matters here. Brands should back up claims with real lab data, and buyers deserve full transparency—clear concentrations, testing for allergies, no secret mixes.
Small studies and hundreds of customer reviews point to fewer new spots, smaller pores and a smoother appearance over weeks or months of steady use. Most users describe less irritation compared to stronger acids. That matches up with my own experience mixing natural exfoliants into a routine: gradual change beats sudden overhauls, and less raw skin means fewer setbacks.
Doctors who’ve kept an eye on this trend remind everyone: what helps mild acne won’t always work for severe cysts or deep scarring. Dermatologists lean on science and experience, and so far, they see shikimic acid as a promising but supplemental player. Those of us who grew up with tried-and-true treatments like benzoyl peroxide and retinoids know the power of consistent, well-studied options when acne won’t budge. But science doesn’t stand still. Shikimic acid, added to gentle cleansers or leave-on lotions, may fit into routines needing a gentler touch.
People seeking a smoother face rarely want snake oil promises. A path forward calls for companies to invest in transparent research, bringing these plant acids from niche trend to proven choice. Reliable makers should publish all clinical test results, not just cherry-picked wins. Consumers—especially teens and those with sensitive skin—should work with dermatologists to mix in new ingredients slowly. Pay attention to how your skin reacts and avoid piling on too many products. A single ingredient or routine change, measured over a few weeks, gives a clearer answer than chasing trends.
Shikimic acid holds potential for fighting breakouts and easing inflammation without the harsh side effects that knock people off their skin-care journey. More honest data and steady communication could help both patients and pros shape routines that clear up more than just hype.
| Names | |
| Preferred IUPAC name | (3R,4S,5R)-3,4,5-Trihydroxycyclohex-1-ene-1-carboxylic acid |
| Other names |
Acidum shikimicum Shikimate 3,4,5-Trihydroxy-1-cyclohexene-1-carboxylic acid |
| Pronunciation | /ʃɪˈkɪmɪk ˈæsɪd/ |
| Identifiers | |
| CAS Number | 138-59-0 |
| 3D model (JSmol) | /data/mol/S/S5632/shikimic-acid.mol |
| Beilstein Reference | 157873 |
| ChEBI | CHEBI:36208 |
| ChEMBL | CHEMBL12307 |
| ChemSpider | 50471 |
| DrugBank | DB02595 |
| ECHA InfoCard | ECHA InfoCard: 100.028.731 |
| EC Number | 3.1.3.25 |
| Gmelin Reference | 12731 |
| KEGG | C00493 |
| MeSH | D015049 |
| PubChem CID | 7000 |
| RTECS number | KI8750000 |
| UNII | QX9C5V5GWG |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C7H10O5 |
| Molar mass | 174.15 g/mol |
| Appearance | White crystalline powder |
| Odor | odorless |
| Density | 1.3 g/cm³ |
| Solubility in water | Soluble |
| log P | -1.11 |
| Vapor pressure | 8.58E-11 mmHg at 25°C |
| Acidity (pKa) | 4.10 |
| Basicity (pKb) | 9.38 |
| Magnetic susceptibility (χ) | -6.2·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.52 |
| Viscosity | Viscosity: 2.53 cP (20 °C) |
| Dipole moment | 2.54 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 259.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -1186.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1676 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | A16AX15 |
| Hazards | |
| Main hazards | Causes skin and eye irritation. Harmful if swallowed. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319 |
| Precautionary statements | P264, P280, P305+P351+P338, P337+P313 |
| Flash point | 82.8°C |
| Autoignition temperature | 410 °C |
| Lethal dose or concentration | LD50 (oral, rat) > 5,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 5 g/kg (oral, rat) |
| NIOSH | RNZH6KJ8PM |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Shikimic Acid is not specifically established by OSHA, NIOSH, or ACGIH. |
| REL (Recommended) | 10 μM |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Quinic acid Chorismic acid Prephenic acid Phenylalanine Tyrosine Tryptophan |
